Literature DB >> 7437711

Selenium 75 selenomethyl cholesterol: a new agent for quantitative functional scintigraphy of the adrenals: physical aspects.

L A Hawkins, K E Britton, B Shapiro.   

Abstract

Fifty-two patients with suspected or known adrenal disorders have been studied with 75Se selenomethyl cholesterol using a rectilinear scanner or gamma camera computer system. Radiation dosimetry was estimated from the blood clearance and whole body retention of 75Se selenomethyl cholesterol. A method of quantitation of adrenal uptake is described, use of which is essential for the separation of normal from hyperactive adrenal glands. The adrenal depth was found to vary between 4.4 and 12 cm. The lack of need for thyroid suppression and the availability and ease of handling and storage of 75Se selenomethyl cholesterol make it preferable to 131I iodo-cholesterol derivatives and the current agent of choice for adrenal imaging.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7437711     DOI: 10.1259/0007-1285-53-633-883

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  4 in total

Review 1.  A black adrenocortical adenoma causing Cushing's syndrome not imaged by radiocholesterol scintigraphy.

Authors:  E Reschini; M Baldini; L Cantalamessa
Journal:  Eur J Nucl Med       Date:  1990

2.  Uptake of 75Se-selenocholesterol by an adrenal cortical carcinoma and its metastases.

Authors:  E Reschini; M Peracchi
Journal:  Eur J Nucl Med       Date:  1984

Review 3.  Targeting cancer using cholesterol conjugates.

Authors:  Awwad A Radwan; Fares K Alanazi
Journal:  Saudi Pharm J       Date:  2013-01-31       Impact factor: 4.330

4.  Clinical experience with the adrenal scanning agents iodine 131-19-iodocholesterol and selenium 75-6-selenomethylcholesterol.

Authors:  E Reschini; A Catania
Journal:  Eur J Nucl Med       Date:  1991
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.